Chapter 127 Treatment and Prophylaxis of Bacterial Infections (Part 7) pot

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 7) pot

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 7) pot

... cefotaxime, rifampin, and clarithromycin, have bioactive metabolites that may contribute to their overall efficacy. Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 7) Distribution ... elimination), by renal excretion of the unchanged or metabolized form, or by a combination of the two processes. For most of the antibacterial drugs, metab...
Ngày tải lên : 08/07/2014, 02:20
  • 6
  • 326
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 2) potx

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 2) potx

... because of a marginally broader spectrum. Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 2) Inhibition of Cell-Wall Synthesis One major difference between bacterial and ... any stage of the synthesis, export, assembly, or cross-linking of peptidoglycan lead to inhibition of bacterial cell growth and, in most cases, to cell dea...
Ngày tải lên : 08/07/2014, 02:20
  • 7
  • 313
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 12) potx

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 12) potx

... consequences; 2 = an interaction of uncertain frequency but of potential clinical importance. b Lovastatin and simvastatin are most affected; pravastatin and atorvastatin are less prone to ... macrolide antibiotics and quinupristin/dalfopristin inhibit the same human metabolic enzyme, CYP3A4, and similar interactions are anticipated. d Ciprofloxacin only. Levofloxacin and m...
Ngày tải lên : 08/07/2014, 02:20
  • 8
  • 213
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 13) pot

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 13) pot

... practice. Table 127- 9 Prophylaxis of Bacterial Infections in Adults Condition Antibacterial Agent Timing or Durationof Prophylaxis Nonsurgical Cardiac lesions susceptible to bacterial Amoxicillin a ... nitrofurantoin 3 times per week for up to 1 year or after sexual intercourse Surgical Clean (cardiac, Cefazolin (vancomycin) c Bef ore and Chapter 12...
Ngày tải lên : 08/07/2014, 02:20
  • 9
  • 215
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 14) pot

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 14) pot

... 2002. Am J Med 118:259, 2005 [PMID: 15745724] Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 14) Duration of Therapy and Treatment Failure Until recently, there was ... Re -treatment of infections for which therapy has failed usually requires a prolonged course (>4 weeks) with combinations of antibacterial agents. Table 127- 10...
Ngày tải lên : 08/07/2014, 02:20
  • 9
  • 248
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 1) ppsx

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 1) ppsx

... Chapter 127. Treatment and Prophylaxis of Bacterial Infections Treatment and Prophylaxis of Bacterial Infections: Introduction The development of vaccines and drugs that prevent and cure bacterial ... membrane potential Not defined a Compounds in parentheses are major representatives for the class. Figure 127- 1 Chapter 127. Treatment and...
Ngày tải lên : 08/07/2014, 02:20
  • 13
  • 290
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 3) ppsx

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 3) ppsx

... susceptible to both components. Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 3) Inhibition of Protein Synthesis Most of the antibacterial agents that inhibit protein ... all purines, and several amino acids. Inhibition of folate synthesis leads to cessation of bacterial cell growth and, in some cases, to bacterial cell death. The...
Ngày tải lên : 08/07/2014, 02:20
  • 5
  • 270
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 4) pdf

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 4) pdf

... penicillins and cephalosporins. One strategy that has been devised for circumventing resistance mediated by β-lactamases is to combine the β-lactam Chapter 127. Treatment and Prophylaxis of Bacterial ... including nalidixic acid and its fluorinated derivatives (ciprofloxacin, levofloxacin, and moxifloxacin), are synthetic compounds that inhibit the activity of the A s...
Ngày tải lên : 08/07/2014, 02:20
  • 7
  • 334
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 5) pdf

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 5) pdf

... permeability and cause active drug efflux from the cytoplasm. Mutations that result in active quinolone efflux are also found in gram-positive bacteria. Chapter 127. Treatment and Prophylaxis of Bacterial ... dihydrofolate reductase for trimethoprim and an altered dihydropteroate synthetase for sulfonamides. Quinolones The most common mechanism of resistance to quino...
Ngày tải lên : 08/07/2014, 02:20
  • 5
  • 297
  • 0
Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 6) doc

Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 6) doc

... Chapter 127. Treatment and Prophylaxis of Bacterial Infections (Part 6) Rifampin Bacteria rapidly become resistant to rifampin by developing mutations in the B subunit of RNA polymerase ... virtue of the acquisition of new genes include hospital-associated strains of gram-negative bacteria, enterococci, and staphylococci and community-acquired strains of...
Ngày tải lên : 08/07/2014, 02:20
  • 5
  • 297
  • 0

Xem thêm

Từ khóa: